Tarsus Pharmaceuticals, Inc. (TARS)
Since Mar 31, 2021, Tarsus Pharmaceuticals, Inc. (TARS) has reported earnings 22 times. On average the shares move ±5.01% post-earnings, with a positive reaction 63.6% of the time. Its largest post-earnings gain was +15.15% (Aug 06, 2025) and its largest decline was -9.33% (Feb 25, 2025). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±5.01%
Positive %
63.6%
Negative %
36.4%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 06, 2026 | ☽ POST | $65.31 | $66.71 | $64.99 | 49,560 | -1.46% | open_in_new |
| Feb 23, 2026 | ☽ POST | $65.75 | $70.43 | $69.59 | 1,397,100 | +7.79% | open_in_new |
| Nov 04, 2025 | ☽ POST | $67.82 | $71.64 | $71.50 | 825,100 | -4.62% | open_in_new |
| Aug 06, 2025 | ☽ POST | $40.89 | $41.93 | $41.64 | 674,200 | +15.15% | open_in_new |
| May 01, 2025 | ☽ POST | $51.74 | $53.89 | $50.30 | 1,058,000 | -5.84% | open_in_new |
| Feb 25, 2025 | ☀ PRE | $47.44 | $47.63 | $41.29 | 1,782,300 | -9.33% | open_in_new |
| Nov 13, 2024 | ☽ POST | $47.60 | $48.84 | $46.51 | 857,900 | +0.31% | open_in_new |
| Aug 08, 2024 | ☽ POST | $23.02 | $24.20 | $23.61 | 902,900 | +13.72% | open_in_new |
| May 08, 2024 | ☽ POST | $37.32 | $38.27 | $37.35 | 917,500 | -8.86% | open_in_new |
| Feb 27, 2024 | ☽ POST | $36.18 | $39.77 | $39.22 | 2,519,100 | -3.44% | open_in_new |
| Nov 09, 2023 | ☽ POST | $16.54 | $16.59 | $15.57 | 929,100 | +12.2% | open_in_new |
| Aug 10, 2023 | ☽ POST | $17.35 | $17.41 | $17.01 | 375,500 | -1.12% | open_in_new |
| May 09, 2023 | ☽ POST | $15.51 | $16.14 | $16.09 | 142,900 | +3.79% | open_in_new |
| Mar 13, 2023 | ☽ POST | $14.12 | $15.09 | $14.19 | 63,300 | +0.85% | open_in_new |
| Nov 09, 2022 | ☽ POST | $18.23 | $18.33 | $17.78 | 86,700 | +1.41% | open_in_new |
| Aug 11, 2022 | ☽ POST | $17.87 | $18.10 | $17.32 | 57,300 | +6.81% | open_in_new |
| May 10, 2022 | ☽ POST | $11.75 | $12.83 | $12.51 | 979,200 | -3.68% | open_in_new |
| Mar 14, 2022 | ☽ POST | $18.95 | $19.07 | $17.53 | 27,100 | +1.03% | open_in_new |
| Nov 09, 2021 | ☽ POST | $27.87 | $28.00 | $27.58 | 18,700 | +1.89% | open_in_new |
| Aug 05, 2021 | ☽ POST | $23.86 | $25.46 | $24.98 | 36,100 | +0.08% | open_in_new |
| May 11, 2021 | ☽ POST | $28.23 | $29.75 | $27.45 | 23,200 | +4.66% | open_in_new |
| Mar 31, 2021 | ☽ POST | $28.31 | $32.44 | $32.23 | 37,500 | +2.17% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±5.01%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260508 | open_in_new SEC.gov |
| 10-Q | 20260506 | open_in_new SEC.gov |
| 8-K | 20260506 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260506 | open_in_new SEC.gov |
| 4 | 20260428 | open_in_new SEC.gov |
| ARS | 20260428 | open_in_new SEC.gov |
| DEFA14A | 20260428 | open_in_new SEC.gov |
| DEF 14A | 20260428 | open_in_new SEC.gov |
Frequently asked about TARS earnings
When does Tarsus Pharmaceuticals, Inc. report earnings next? expand_more
Tarsus Pharmaceuticals, Inc. (TARS)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does TARS stock move after earnings? expand_more
Over 22 reports, TARS has moved an average of ±5.01% the session after earnings, closing higher 63.6% of the time.
What was TARS's biggest post-earnings move? expand_more
TARS's largest post-earnings gain on record was +15.15% on Aug 06, 2025, and its largest decline was -9.33% on Feb 25, 2025.
Where can I find Tarsus Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Tarsus Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right